Lushang Freda Pharmaceutical Co.,Ltd. (600223.SS) SHH

Currency In CNY

AD

Valuation

Market Cap7.48B
Enterprise Value4.74B
P/E Ratio33.86
PEG Ratio-1.11
Price/Sales Ratio1.54
Price/Book Ratio1.39
Enterprise/Revenue0.81
Enterprise/EBITDA9.97

Fiscal Year

Fiscal YearDecember 31, 2025
Most Recent QuarterMarch 31, 2026

Profitability

Profit Margin0.05
Operating Margin0.05
AD

Management Effectiveness

Return On Assets0.03
Return On Equity0.04

Income Statement

Revenue3.63B
Revenue/Share3.46
Gross Profit1.85B
EBITDA414.07M
Net Income187.75M
Diluted EPS0.18

Balance Sheet

Total Cash2.87B
Total Cash/Share2.7
Total Debt180.81M
Total Debt/Equity0.04
Current Ratio4.61
Book Value Per Share4.69

Price History

52-Week Change-34.35
52-Week High8.73
52-Week Low4.89
Moving Average 50 Days5.53
Moving Average 200 Days6.82

Statistics

Average Volume8.28M
Shares Outstanding1.02B
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0.06
Trailing Annual Dividend Yield1.02
Payout Ratio0.01
Last Split Factor5:4
Last Split DateFebruary 20, 2006
AD